ngenla
pfizer europe ma eeig - somatrogon - growth and development - hypofÝzy a hypotalamickÝch hormÓny a ich analÓgy - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
skytrofa (previously lonapegsomatropin ascendis pharma)
ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hypofýzové a hypotalamické hormóny a analógy - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.
elfabrio
chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabryho choroba - iné alimentárny trakt a metabolizmus výrobky, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).
mastodynon
bionorica se, nemecko - homeopatiká - 93 - homeopatica
klimakt-heel
biologische heilmittel heel gmbh, nemecko - iné liečivá - 93 - homeopatica
miraklide 10 mg
vipharm s.a., poľsko - escitalopram - 30 - antidepressiva
miraklide 15 mg
vipharm s.a., poľsko - escitalopram - 30 - antidepressiva
miraklide 20 mg
vipharm s.a., poľsko - escitalopram - 30 - antidepressiva
tracrium
aspen pharma trading limited, Írsko - atrakurium - 63 - myorelaxantia
madlo kovové kovex
kovex v. d. pod budínem 1178 51611 rychnov nad knežnou Česká republika -